Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| IDERA PHARMACEUTICALS, INC. | 830,294 | reported | 17 Jan 2023 | tx 6+2,202,076−14,115 |
| Revance Therapeutics, Inc. | 8,000 | reported | 07 May 2015 | tx 10+3,120,650−3,096,650 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Jan 2023 | CONVERSION | IDERA PHARMACEUTICALS, INC. | 830,294 | — | deriv |
| 17 Jan 2023 | CONVERSION | IDERA PHARMACEUTICALS, INC. | 14,115 | — | deriv |
| 28 Sept 2022 | OTHER | IDERA PHARMACEUTICALS, INC. | 5 | — | |
| 28 Sept 2022 | OTHER | IDERA PHARMACEUTICALS, INC. | 14,115 | — | deriv |
| 28 Sept 2022 | OTHER | IDERA PHARMACEUTICALS, INC. | 1,343,547 | — | deriv |
| 28 Sept 2022 | OTHER | IDERA PHARMACEUTICALS, INC. | 14,115 | — | deriv |
| 07 May 2015 | GRANT_AWARD | Revance Therapeutics, Inc. | 8,000 | 0.00 USD | deriv |
| 08 Apr 2014 | GRANT_AWARD | Revance Therapeutics, Inc. | 8,000 | 0.00 USD | deriv |
| 11 Feb 2014 | CONVERSION | Revance Therapeutics, Inc. | 2,039,382 | — | |
| 11 Feb 2014 | CONVERSION | Revance Therapeutics, Inc. | 658,551 | — | |
| 11 Feb 2014 | EXERCISE | Revance Therapeutics, Inc. | 398,717 | — | |
| 11 Feb 2014 | CONVERSION | Revance Therapeutics, Inc. | 500,039 | — | deriv |
| 11 Feb 2014 | EXERCISE | Revance Therapeutics, Inc. | 398,717 | — | deriv |
| 11 Feb 2014 | CONVERSION | Revance Therapeutics, Inc. | 1,539,343 | — | deriv |
| 11 Feb 2014 | CONVERSION | Revance Therapeutics, Inc. | 658,551 | — | deriv |